Filgrastim Completed Phase 2 Trials for Paroxysmal Hemoglobinuria, Nocturnal / Aplastic Anaemia (AA) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00004464Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria